Does 1-alpha,25-dihydroxyvitamin D3 (calcitriol) enhance corticosteroid activity in steroid refractory asthma? A randomised control trial to test whether active vitamin D can improve the clinical response to steroids in asthmatic patients.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 06 Dec 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Calcitriol (Primary) ; Prednisolone
Indications Asthma
Focus Biomarker; Therapeutic Use

Most Recent Events

28 Apr 2014 Primary endpoint 'Forced-expiratory-volume-in-1-second' has not been met.
28 Apr 2014 Results published in the Journal of Allergy and Clinical Immunology.
20 Apr 2012 Official title amended and additional lead trial centre added as reported by European Clinical Trials Database.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight